|
|
|
Prostate cancer |
Prostate cancer or adenocarcinoma of the prostate is the most commonly diagnosed cancer in men accounting for nearly 200,000 cases per year and it is the second leading cause of death in men with 32,000 annual deaths.
Fortunately, the great majority of men are diagnosed early and are asymptomatic at the time of diagnosis due to the routine use of the prostate specific antigen (PSA) blood test.
Annual prostate examination and PSA testing is recommended in men over 50 years of age. Earlier testing is indicated in black males and in men with significant family history. While PSA is not a "cancer test", since it can be elevated in men with prostatic enlargement and prostatitis, it can provide useful information particularly in men with rising PSA's. If your PSA is elevated there is a new test called
PCA3PLUS,
www.bostwicklaboratories.com which may provide additional diagnostic information in conjunction with the PSA. If indicated, a transrectal ultrasound (TRUS) and prostate biopsy is performed.
There are a host of treatments available for the management of prostate cancer such as radiation, prostate Seed Implants- (Brachytherapy) and surgical approaches.
| |
|
|
|
